Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders
Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2000-09, Vol.206 (1), p.75-83 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 83 |
---|---|
container_issue | 1 |
container_start_page | 75 |
container_title | International journal of pharmaceutics |
container_volume | 206 |
creator | Chew, Nora Y.K Bagster, David F Chan, Hak-Kim |
description | Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (
Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm
3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF
max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF
max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG. |
doi_str_mv | 10.1016/S0378-5173(00)00516-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72383554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517300005160</els_id><sourcerecordid>72383554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</originalsourceid><addsrcrecordid>eNqFkUtrFTEUgIMo9rb6E5QsRCo4ejKZPGYlpVQtFFyo65CbnNhoZnJN5ra0v96092KXXR04fOf1HUJeMfjAgMmP34Er3Qmm-DHAOwDBZAdPyIppxTs-KPmUrP4jB-Sw1t8AIHvGn5MDxkBozfoV-XMWArqF5kA3tizRJaQ13uJ7amOhIeVramdP43xpExbq8So6pHmmyyVSiyXXnGK1S2yp1sPHmn3cTtSVPOVf6cbZBekmX3ss9QV5Fmyq-HIfj8jPz2c_Tr92F9--nJ-eXHRuEHLpUClwQQ5WyjH0QqO0yFXLjDCIgN6GdqJUo7BaS6bHHkcxqjUGN-LaDciPyNtd303Jf7dYFzPF6jAlO2PeVqN6rrkQQwPFDmzb1lowmE2Jky03hoG5s2zuLZs7hQbA3Fs20Ope7wds1xP6h6q91ga82QO2OptCsbOL9YETMPZCNOzTDsNm4ypiMdVFnB36WNpTjM_xkU3-AX0Amkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72383554</pqid></control><display><type>article</type><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</creator><creatorcontrib>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</creatorcontrib><description>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (
Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm
3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF
max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF
max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(00)00516-0</identifier><identifier>PMID: 11058812</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aerosol inhaler ; Aerosols ; Air flow ; Amorphous powders ; Anti-Asthmatic Agents - chemistry ; Biological and medical sciences ; Cromolyn Sodium - chemistry ; Disodium cromoglycate ; General pharmacology ; Histamine and antagonists. Allergy ; Medical sciences ; Nebulizers and Vaporizers ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Powders</subject><ispartof>International journal of pharmaceutics, 2000-09, Vol.206 (1), p.75-83</ispartof><rights>2000 Elsevier Science B.V.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517300005160$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1509255$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11058812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chew, Nora Y.K</creatorcontrib><creatorcontrib>Bagster, David F</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (
Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm
3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF
max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF
max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</description><subject>Aerosol inhaler</subject><subject>Aerosols</subject><subject>Air flow</subject><subject>Amorphous powders</subject><subject>Anti-Asthmatic Agents - chemistry</subject><subject>Biological and medical sciences</subject><subject>Cromolyn Sodium - chemistry</subject><subject>Disodium cromoglycate</subject><subject>General pharmacology</subject><subject>Histamine and antagonists. Allergy</subject><subject>Medical sciences</subject><subject>Nebulizers and Vaporizers</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Powders</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtrFTEUgIMo9rb6E5QsRCo4ejKZPGYlpVQtFFyo65CbnNhoZnJN5ra0v96092KXXR04fOf1HUJeMfjAgMmP34Er3Qmm-DHAOwDBZAdPyIppxTs-KPmUrP4jB-Sw1t8AIHvGn5MDxkBozfoV-XMWArqF5kA3tizRJaQ13uJ7amOhIeVramdP43xpExbq8So6pHmmyyVSiyXXnGK1S2yp1sPHmn3cTtSVPOVf6cbZBekmX3ss9QV5Fmyq-HIfj8jPz2c_Tr92F9--nJ-eXHRuEHLpUClwQQ5WyjH0QqO0yFXLjDCIgN6GdqJUo7BaS6bHHkcxqjUGN-LaDciPyNtd303Jf7dYFzPF6jAlO2PeVqN6rrkQQwPFDmzb1lowmE2Jky03hoG5s2zuLZs7hQbA3Fs20Ope7wds1xP6h6q91ga82QO2OptCsbOL9YETMPZCNOzTDsNm4ypiMdVFnB36WNpTjM_xkU3-AX0Amkw</recordid><startdate>20000925</startdate><enddate>20000925</enddate><creator>Chew, Nora Y.K</creator><creator>Bagster, David F</creator><creator>Chan, Hak-Kim</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000925</creationdate><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><author>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Aerosol inhaler</topic><topic>Aerosols</topic><topic>Air flow</topic><topic>Amorphous powders</topic><topic>Anti-Asthmatic Agents - chemistry</topic><topic>Biological and medical sciences</topic><topic>Cromolyn Sodium - chemistry</topic><topic>Disodium cromoglycate</topic><topic>General pharmacology</topic><topic>Histamine and antagonists. Allergy</topic><topic>Medical sciences</topic><topic>Nebulizers and Vaporizers</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Powders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chew, Nora Y.K</creatorcontrib><creatorcontrib>Bagster, David F</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chew, Nora Y.K</au><au>Bagster, David F</au><au>Chan, Hak-Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2000-09-25</date><risdate>2000</risdate><volume>206</volume><issue>1</issue><spage>75</spage><epage>83</epage><pages>75-83</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (
Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm
3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF
max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF
max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11058812</pmid><doi>10.1016/S0378-5173(00)00516-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2000-09, Vol.206 (1), p.75-83 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_72383554 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aerosol inhaler Aerosols Air flow Amorphous powders Anti-Asthmatic Agents - chemistry Biological and medical sciences Cromolyn Sodium - chemistry Disodium cromoglycate General pharmacology Histamine and antagonists. Allergy Medical sciences Nebulizers and Vaporizers Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Powders |
title | Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A33%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20particle%20size,%20air%20flow%20and%20inhaler%20device%20on%20the%20aerosolisation%20of%20disodium%20cromoglycate%20powders&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Chew,%20Nora%20Y.K&rft.date=2000-09-25&rft.volume=206&rft.issue=1&rft.spage=75&rft.epage=83&rft.pages=75-83&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(00)00516-0&rft_dat=%3Cproquest_cross%3E72383554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72383554&rft_id=info:pmid/11058812&rft_els_id=S0378517300005160&rfr_iscdi=true |